申请人:E. I. Du Pont de Nemours & Co.
公开号:US04657919A1
公开(公告)日:1987-04-14
Described are compounds of the formula ##STR1## wherein R is hydrogen, lower alkyl, halo, cyano, hydroxy, amino, lower alkylamino, --CH.sub.2 NH.sub.2, --CH.sub.2 OH or --COOR"; R' is hydrogen, lower cycloalkyl or lower alkyl; R' is lower alkenyl, lower alkynyl, lower cycloalkyl, --(W).sub.n Y wherein W is straight or branched chain lower alkyl or lower alkenyl, n is 0 to 5, and Y is Ar, lower cycloalkyl, lower alkenyl, lower alkynyl, --COOZ wherein Z is lower alkyl, ##STR2## or NAB wherein A and B are, independently, lower alkyl, benzyl or substituted benzyl, and Ar is 2, 3 or 4-pyridyl, pyridazinyl, pyrimidinyl, quinolyl, isoquinolyl, phthalazinyl, quinazolinyl, thiazolyl, phenyl, benzyl, furyl, tetrahydrofuryl or thienyl, unsubstituted or substituted with lower alkyl, lower alkoxy, halo, amino, or --CF.sub.3 ; R"' is --COOR", ##STR3## and X is oxygen or nitrogen; or a pharmaceutically acceptable salt thereof, and their use in the treatment of impaired ventricular myocardial contractility. The compounds exhibit cardiotonic activity.
描述了公式##STR1##的化合物,其中R是氢、低级烷基、卤素、氰基、羟基、氨基、低级烷基亚胺、--CH.sub.2 NH.sub.2、--CH.sub.2 OH或--COOR";R'是氢、低级环烷基或低级烷基;R'是低级烯基、低级炔基、低级环烷基、--(W).sub.n Y,其中W是直链或支链低级烷基或低级烯基,n是0到5,Y是Ar、低级环烷基、低级烯基、低级炔基、--COOZ,其中Z是低级烷基、##STR2##或NAB,其中A和B独立地是低级烷基、苄基或取代苄基,Ar是2、3或4-吡啶基、吡啶嗪基、嘧啶基、喹诺酮基、异喹诺酮基、酞嗪基、喹唑啉基、噻唑基、苯基、苄基、呋喃基、四氢呋喃基或噻吩基,未取代或取代有低级烷基、低级烷氧基、卤素、氨基或--CF.sub.3;R"'是--COOR",##STR3##,X是氧或氮;或其药物可接受的盐,及其在治疗心室心肌收缩力受损中的应用。这些化合物具有强心作用。